XWELL Inc
XWEL1.000USD
-0.010-0.99%
Market hours （ET）Quotes delayed by 15 min
5.26MMarket Cap
LossP/E TTM
More Details of XWELL Inc Company
XWELL, Inc. is a global health and wellness holding company. The Company operates through four segments: XpresTest, XpresSpa, Treat, and Naples Wax Center. The XpresTest segment provides diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the centers for disease control and prevention (CDC’s) bio-surveillance program. XpresTest’s HyperPointe business provides a range of service and support options for its customers, including technical support services and advanced services. The XpresSpa segment provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. Treat segment is a wellness brand that provides access to wellness services for travelers at on-site centers. Naples Wax Center segment operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.
Company Info
Ticker SymbolXWEL
Company nameXWELL Inc
IPO dateJun 18, 2010
CEOMr. Ezra T. Ernst
Number of employees246
Security typeOrdinary Share
Fiscal year-endJun 18
Address- -
City- -
Stock exchangeNASDAQ Capital Market Consolidated
Country- -
Postal code- -
Phone- -
Website- -
Ticker SymbolXWEL
IPO dateJun 18, 2010
CEOMr. Ezra T. Ernst
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Robert Weinstein
Mr. Robert Weinstein
Independent Director
Independent Director
115.23K
+1372.79%
Mr. Michael Lebowitz
Mr. Michael Lebowitz
Independent Director
Independent Director
111.12K
+756.50%
Ms. Gaeelle S. Wizenberg
Ms. Gaeelle S. Wizenberg
Independent Director
Independent Director
--
--
Mr. Bruce T. Bernstein
Mr. Bruce T. Bernstein
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Ezra T. Ernst
Mr. Ezra T. Ernst
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Ian Brown
Mr. Ian Brown
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Robert Weinstein
Mr. Robert Weinstein
Independent Director
Independent Director
115.23K
+1372.79%
Mr. Michael Lebowitz
Mr. Michael Lebowitz
Independent Director
Independent Director
111.12K
+756.50%
Ms. Gaeelle S. Wizenberg
Ms. Gaeelle S. Wizenberg
Independent Director
Independent Director
--
--
Mr. Bruce T. Bernstein
Mr. Bruce T. Bernstein
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Ezra T. Ernst
Mr. Ezra T. Ernst
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Ian Brown
Mr. Ian Brown
Chief Financial Officer
Chief Financial Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2024
FY2023
FY2022
No Data
By RegionUSD
Name
Revenue
Proportion
United States
27.81M
82.05%
All other countries
6.08M
17.95%
By Business
By Region
No Data
Shareholding Stats
Updated: Thu, Jun 5
Updated: Thu, Jun 5
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Blackwells Capital LLC
9.79%
CPC Pain & Wellness SPV LLC
7.49%
Bernstein Bruce G
4.56%
Weinstein (Robert)
2.19%
Lebowitz (Michael)
2.11%
Other
73.85%
Shareholders
Shareholders
Proportion
Blackwells Capital LLC
9.79%
CPC Pain & Wellness SPV LLC
7.49%
Bernstein Bruce G
4.56%
Weinstein (Robert)
2.19%
Lebowitz (Michael)
2.11%
Other
73.85%
Shareholder Types
Shareholders
Proportion
Individual Investor
11.42%
Hedge Fund
10.46%
Corporation
7.49%
Investment Advisor
3.72%
Investment Advisor/Hedge Fund
1.23%
Research Firm
0.05%
Other
65.63%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
52
1.81M
34.37%
+918.03K
2025Q1
62
1.31M
24.95%
+444.81K
2024Q4
65
1.34M
25.49%
+412.54K
2024Q3
73
1.43M
27.22%
+617.66K
2024Q2
80
745.53K
17.82%
+257.00K
2024Q1
85
388.21K
9.29%
-169.59K
2023Q4
101
489.50K
11.72%
-328.62K
2023Q3
111
540.00K
12.92%
-296.62K
2023Q2
113
563.97K
13.51%
-270.83K
2023Q1
120
540.45K
12.88%
-359.65K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Blackwells Capital LLC
515.09K
9.79%
+515.09K
--
Aug 06, 2024
CPC Pain & Wellness SPV LLC
394.20K
7.49%
--
--
Aug 09, 2024
Bernstein Bruce G
239.88K
4.56%
+200.93K
+515.78%
Jun 02, 2025
Weinstein (Robert)
115.23K
2.19%
+107.41K
+1372.79%
Jun 02, 2025
Lebowitz (Michael)
111.12K
2.11%
+98.15K
+756.50%
Jun 02, 2025
Wizenberg (Gaeelle Sandra)
90.70K
1.72%
+89.20K
+5946.53%
Jun 02, 2025
BlackRock Institutional Trust Company, N.A.
82.69K
1.57%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
77.07K
1.47%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
48.42K
0.92%
-5.14K
-9.60%
Mar 31, 2025
Ernst (Ezra)
31.13K
0.59%
--
--
Apr 25, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Sep 27, 2023
Merger
20<1
Sep 27, 2023
Merger
20<1
Sep 27, 2023
Merger
20<1
Sep 27, 2023
Merger
20<1
Jun 10, 2020
Merger
3<1
Jun 10, 2020
Merger
3<1
Date
Type
Ratio
Sep 27, 2023
Merger
20<1
Sep 27, 2023
Merger
20<1
Sep 27, 2023
Merger
20<1
Sep 27, 2023
Merger
20<1
Jun 10, 2020
Merger
3<1
Jun 10, 2020
Merger
3<1
Jun 10, 2020
Merger
3<1
Jun 10, 2020
Merger
3<1
